INFORMATION ON THE ENTERING INTO AMGROS COMMISSION AGREEMENTS FOR SELECTED MEDICINES IN 2026 Q4

The Amgros I S in Denmark from Europe region has released this tender for This advance notice is an information about Amgros expected conclusion of commissioning agreements for covered medicinal products in section 3 1 Amgros will enter into commissioning agreements with all interested parties and Amgros therefore encourages all potential entrants to enter into Amgros commissioning agreements for the medicinal products below to express interest by sending relevant information including price to udbu amgros dk Amgros expects to offer the covered medicinal products as framework agreements in a public tender at a later date and the expectation is that the tender will be published within the next 12 months but this will depend on several factors Even when the tender has been published Amgros will continue to enter into commissioning agreements on standard terms with interested parties but it will not be possible to negotiate terms including the price of the commissioning agreement from that point on The final terms for the tenders will be stated in the tender materials when they are published In relation to the section Information about the announcement it should be noted that the tender announcement for the covered medicinal products will be published when the tender is published and that the date in the section is only indicative with tender notice no. 664642-2026 published on 07 Oct 2026. The tender is due to expire on 27 Dec 2026. This tender is sourced from TED Europa and is eligible for suppliers interested in Pharmaceutical products. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 15291838.